19 November 2020
We are delighted to announce the incorporation of ImmunoServ Ltd., a specialist contract research organisation in the immunology sector.
The company was founded in October 2020 by immunologists from Cardiff University, with excellent links to local NHS facilities. We specialise in performing pre-clinical contract research in the immunology field and clinical studies of immunotherapeutics: a core focus of ImmunoServ will be to perform immunoassays to deliver primary and secondary outcome measures on upcoming cancer immunotherapy trials. To find out whether our capabilities could help with your product development, see more info on our services and expertise or contact us for more information.
ImmunoServ also has a strong R&D pipeline, with the aim of commercialising several T cell-based immunological assays and therapeutics for use in research and healthcare settings. Find out more about these projects here.